AzTrials
AzTrials

Adolescent DevelopmentNCT06759779

Inspiratory and Expiratory Muscle Training in Adolescent Volleyball Players

A study testing inspiratory muscle training and expiratory muscle training in people with Adolescent Development, run by Gazi University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will investigate the effects of inspiratory and expiratory muscle training on respiratory muscle strength, pulmonary function, and performance status in adolescent athletes Read more about this study

Who is it for?
Ages 12 to 18 years, women onlyHealthy volunteers can take part
Conditions the study is for
Adolescent Development
What is being tested?
inspiratory muscle training and expiratory muscle training
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jul 2023to 1 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Athletes aged 12-18 who train at a submaximal level at least 3 days a week

Who cannot join

  • Adolescents with any history of chronic lung disease
  • unable to comply with the test and training
  • unwilling to participate in the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gazi University

    Ankara, Emek, 06490

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Inspiratory and Expiratory Muscle Strength Training on Respiratory Functions and Performance in Adolescent Volleyball Players

This study will investigate the effects of inspiratory and expiratory muscle training on respiratory muscle strength, pulmonary function, and performance status in adolescent athletes

Read the detailed description

In the literature, it has been shown in a limited number of studies that respiratory muscle training in sports such as football, cycling, swimming, and rugby reduces athletes' perceived exertion levels. However, the effects of inspiratory and expiratory muscle training on respiratory muscle strength, pulmonary function, and performance status in adolescent athletes are still unclear. Therefore, this study has been planned.

Being tested
inspiratory muscle training, expiratory muscle training
Keywords
pulmonary functions, muscle training, adolescent health, volleyball players

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • inspiratory muscle trainingDevice

    Inspiratory muscle training will be performed

  • expiratory muscle trainingDevice

    Expiratory muscle training will be performed

Study groups in NCT06759779
Study groupRoleWhat they receive
inspiratory muscle training groupExperimentalNot described
Receives: Device: inspiratory muscle training
expiratory muscle training groupExperimentalNot described
Receives: Device: expiratory muscle training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Respiratory muscle strength

    Maximal inspiratory and expiratory muscle strength will be evaluated using mouth pressure device .

    Measured: First day

  2. Diaphragm thickness

    Diaphragm thickness will be assessed using ultrasonography.

    Measured: Second day

Secondary outcomes (11)
  1. Constant load-inspiratory muscle endurance test

    It will be evaluated with inspiratory muscle trainer

    Measured: First day

  2. FEV1

    ulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. FEV1 will be evaluated. The percentage of predicted value <70% will be expressed as abnormal

    Measured: First day

  3. FVC

    ulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. FEV1 will be evaluated. The percentage of predicted value <70% will be expressed as abnormal

    Measured: First day

  4. FEV1/FVC

    Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. FEV1/FVC will be evaluated.

    Measured: First day

  5. PEF

    Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. PEF will be evaluated. The percentage of predicted value <70% will be expressed as abnormal

    Measured: First day

  6. FEF2575

    Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. FEF2575 will be evaluated. The percentage of predicted value <50% will be expressed as abnormal

    Measured: First day

  7. Athletic performance

    Performance will be evaluated with shuttle run test

    Measured: second day

  8. Fat free mass Body compositions

    Fat free mass (kg) will be evaluated with bioelectrical impedance analyzer

    Measured: second day

  9. Fat mass Body compositions

    Fat mass (kg) will be evaluated with bioelectrical impedance analyzer

    Measured: second day

  10. Fat percentage Body compositions

    Fat percentage (%) will be evaluated with bioelectrical impedance analyzer

    Measured: second day

  11. Diaphragm stiffness

    Diaphragm stiffness will be assessed using shear-wave elastography.

    Measured: second day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2025
  2. Study start1 Jul 2023
  3. Primary completion1 Feb 2025
  4. Study completion1 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06759779
Sponsor's protocol ID
474032
Status last verified
Sep 2026
First submitted
13 Dec 2024
Last updated
22 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Celik Z, Demirtas G, Guzel NA, Sendur HN, Keles MN, Karatas N, Kokturk N. Comparative effects of inspiratory and expiratory muscle training on diaphragm adaptations and respiratory function in adolescent athletes: a randomized-controlled study. BMC Pediatr. 2026 Oct 8;26(1):996. doi: 10.1186/s12887-026-07817-z.

    PubMed 42870242

Questions about this trial

What is this clinical trial studying?

A study testing inspiratory muscle training and expiratory muscle training in people with Adolescent Development, run by Gazi University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Respiratory muscle strength (time frame: First day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06759779, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in